Literature DB >> 6244353

Separation of human blood monocytes and lymphocytes on a continuous Percoll gradient.

F Gmelig-Meyling, T A Waldmann.   

Abstract

A method for separation of human blood monocytes and lymphocytes is described. Mononuclear leukocytes are centrifuged on a continuous gradient of colloidal silica particles (Percoll) in phosphate-buffered saline. This leads to formation of 4 bands: a layer containing dead material (if present) which did not enter the gradient; a layer near the bottom of the tube containing granulocytes and red cells, and two other bands in between. The upper one is enriched for monocytes (av. 78%) and the lower one for lymphocytes (av. 98%). The final yields of these cell types are 73% and 79%, respectively, and their viability is greater than 95%. No functional impairments could be detected by different criteria including the ability of B lymphocytes to produce immunoglobulins when stimulated with pokeweed mitogen and the ability of monocytes to phagocytize opsonized red cells and latex particles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244353     DOI: 10.1016/0022-1759(80)90077-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  46 in total

1.  Monocyte heterogeneity in angiotensin-converting enzyme induction mediated by autologous T lymphocytes.

Authors:  J H Ryu; Z Vuk-Pavlović; M S Rohrbach
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  The Effects of Probiotic Supplementation on Genetic and Metabolic Profiles in Patients with Gestational Diabetes Mellitus: a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Mahtab Babadi; Ahmad Khorshidi; Esmat Aghadavood; Mansooreh Samimi; Elham Kavossian; Fereshteh Bahmani; Alireza Mafi; Rana Shafabakhsh; Mahbobeh Satari; Zatollah Asemi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

3.  Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion.

Authors:  S L Newman; C Bucher; J Rhodes; W E Bullock
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Skeletal muscle cell populations. Separation and partial characterization of fibroblast-like cells from embryonic tissue using density centrifugation.

Authors:  Z Yablonka-Reuveni; M Nameroff
Journal:  Histochemistry       Date:  1987

5.  Increased interleukin 1 beta production of macrophages by proteoglycan fragments deriving from articular cartilage in vitro.

Authors:  E Gurr; A Ahrens; G Lonnemann; A Delbrück
Journal:  Agents Actions       Date:  1990-01

6.  Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor.

Authors:  H Vlassara; L Moldawer; B Chan
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii.

Authors:  T Hara; S Ohashi; Y Yamashita; T Abe; H Hisaeda; K Himeno; R A Good; K Takeshita
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

8.  Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro.

Authors:  C D Bucana; L C Hoyer; A J Schroit; E Kleinerman; I J Fidler
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

9.  Monoclonal antibodies EBU-141 (CDw75) and EBU-65 allow reliable distinction between mature and pre-B-cell tumors in suspension and on tissue sections.

Authors:  M Gramatzki; R Burger; J Kraus; U Lauer; P Rohwer; G Eger; J R Kalden; F Henschke
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

10.  Acute effects of smoking and high experimental exposure to environmental tobacco smoke (ETS) on the immune system.

Authors:  S Hockertz; A Emmendörffer; G Scherer; T Ruppert; H Daube; A R Tricker; F Adlkofer
Journal:  Cell Biol Toxicol       Date:  1994-06       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.